Valuation Joinn Laboratories(China)Co.,Ltd. Hong Kong S.E.
Stocks
6127
CNE100004BP3
Biotechnology & Medical Research
|
Market Closed -
Hong Kong S.E.
04:08:25 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 24.50 HKD | +8.89% |
|
-8.10% | +18.93% |
| 10-28 | Joinn Laboratories(China)Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 | CI |
| 10-28 | Joinn Laboratories Posts Higher Q3 Attributable Profit, Revenue Up | MT |
Company Valuation: Joinn Laboratories(China)Co.,Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 40,246 | 29,328 | 16,313 | 11,374 | 23,924 | 31,595 | - | - |
| Change | - | -27.13% | -44.38% | -30.28% | 110.35% | 32.07% | - | - |
| Enterprise Value (EV) 1 | 36,161 | 26,442 | 13,478 | 10,430 | 23,032 | 29,826 | 29,561 | 29,203 |
| Change | - | -26.88% | -49.03% | -22.61% | 120.83% | 29.5% | -0.89% | -1.21% |
| P/E | 76.4x | 29.2x | 44.7x | 166x | 87.5x | 39.4x | 59.7x | 42.9x |
| PBR | 6.16x | 3.82x | 2.15x | 1.54x | 3.15x | 3.91x | 3.78x | 3.55x |
| PEG | - | 0.3x | -0.7x | -2x | 0x | 0x | -1.8x | 1.1x |
| Capitalization / Revenue | 26.5x | 12.9x | 6.86x | 5.64x | 14.4x | 17x | 14.5x | 11.5x |
| EV / Revenue | 23.8x | 11.7x | 5.67x | 5.17x | 13.9x | 16.1x | 13.5x | 10.6x |
| EV / EBITDA | 50x | 19.8x | 21.5x | 48.8x | 46x | 105x | 50.5x | 37.1x |
| EV / EBIT | 56.2x | 21.6x | 26.6x | 152x | 68x | 14,769x | 167x | 63.1x |
| EV / FCF | 80.6x | 38x | 31.3x | 153x | 76.5x | 65x | 199x | 137x |
| FCF Yield | 1.24% | 2.63% | 3.19% | 0.65% | 1.31% | 1.54% | 0.5% | 0.73% |
| Dividend per Share 2 | 0.1837 | 0.2857 | 0.16 | 0.03 | 0.12 | 0.28 | 0.155 | 0.21 |
| Rate of return | 0.31% | 0.68% | 0.67% | 0.18% | 0.34% | 0.6% | 0.33% | 0.45% |
| EPS 2 | 0.7704 | 1.429 | 0.53 | 0.1 | 0.4 | 1.189 | 0.785 | 1.092 |
| Distribution rate | 23.8% | 20% | 30.2% | 30% | 30% | 23.6% | 19.7% | 19.2% |
| Net sales 1 | 1,517 | 2,268 | 2,376 | 2,018 | 1,658 | 1,858 | 2,186 | 2,754 |
| EBITDA 1 | 723.1 | 1,333 | 626.1 | 213.9 | 500.7 | 283.3 | 585.1 | 787.8 |
| EBIT 1 | 643 | 1,226 | 507.1 | 68.81 | 338.9 | 2.02 | 176.9 | 462.6 |
| Net income 1 | 557 | 1,074 | 397 | 74.08 | 297.8 | 787.9 | 373.6 | 795.6 |
| Net Debt 1 | -4,085 | -2,886 | -2,835 | -943.6 | -891.7 | -1,770 | -2,034 | -2,392 |
| Reference price 2 | 58.89 | 41.72 | 23.71 | 16.63 | 35.01 | 46.85 | 46.85 | 46.85 |
| Nbr of stocks (in thousands) | 747,243 | 749,950 | 746,974 | 733,989 | 733,375 | 733,375 | - | - |
| Announcement Date | 2/24/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.08x | 6.33x | 12.4x | 1.75% | 63.48B | |
| 30.03x | 7.96x | 26.08x | 0.05% | 54.55B | |
| 37.03x | 6.57x | 19.63x | 0.87% | 53.59B | |
| 35.05x | 3.37x | 14.55x | -.--% | 44.75B | |
| 48.28x | 5.55x | 30.42x | -.--% | 41.62B | |
| -19.33x | 186.93x | -20.57x | -.--% | 39.91B | |
| 30.28x | 7.94x | 20.6x | 0.4% | 32.47B | |
| 36.51x | 6.64x | 22.27x | -.--% | 26.7B | |
| 26.96x | 5.67x | 14.71x | -.--% | 23.36B | |
| Average | 26.88x | 26.33x | 15.57x | 0.34% | 42.27B | |
| Weighted average by Cap. | 26.55x | 25.23x | 15.68x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 603127 Stock
- 6127 Stock
- Valuation Joinn Laboratories(China)Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
